Overview Monotherapy With Levetiracetam in Patients Suffering From Epilepsy. Status: Completed Trial end date: 2007-05-29 Target enrollment: Participant gender: Summary An open-label follow-up trial assessing the long term safety of levetiracetam as per adverse events reporting. Phase: Phase 3 Details Lead Sponsor: UCB PharmaUCB Pharma SATreatments: EtiracetamLevetiracetamPiracetam